From GlobeNewswire: 2025-02-12 22:47:05

atai Life Sciences, a biopharmaceutical company, announced the pricing of 26,190,477 common shares at $2.10 per share, with a 30-day option for an additional 3,928,571 shares. The offering is expected to generate around $55 million in gross proceeds, to be used for general corporate purposes and clinical development. The offering is set to close on February 14, 2025, with Berenberg as the sole bookrunner. The securities are offered under an effective shelf registration statement filed with the SEC. atai aims to revolutionize mental health treatment with innovative therapies for depression and anxiety.



Read more at GlobeNewswire: atai Life Sciences Announces Pricing of Public Offering of